NEW ORLEANS—About 38% of patients with migraine are candidates for preventive treatment, yet less than a third of these migraineurs actually use such drugs, according to new evidence-based guidelines. The revised guidelines, codeveloped by the American Academy of Neurology (AAN) and the American Headache Society (AHS), were announced at the 64th Annual Meeting of the AAN and were published in the April 24, 2012, issue of Neurology.
“Studies show that migraine is underrecognized and undertreated,” said guidelines author Stephen D. Silberstein, MD, Professor of Neurology and Director of the Jefferson Headache Center at Thomas Jefferson University in Philadelphia. According to Dr. Silberstein, candidates for migraine prevention include the following people:
More Headlines